Logo

American Heart Association

  5
  0


Final ID: OGCTP19

Trial of Endovascular Therapy for Acute Basilar Artery Occlusion with Large Infarct

Abstract Body: Background and aims: There are no randomized trials examining the best treatment for acute basilar artery occlusion with large Infarct. The primary aim of this study is to assess the safety and efficacy of thrombectomy for stroke due to basilar artery occlusion in patients with large infarct within 24 hours from symptom onset.
Methods: This is a prospective, multi-center, randomized, controlled, open-label and blinded-endpoint trial involving patients with acute basilar-artery occlusion and a posterior circulation Acute Stroke Prognosis Early CT score (pc-ASPECTS) of 3 to 5 (range, 0 to 10, with lower values indicating larger infarction). The randomization employs a 1:1 ratio of mechanical thrombectomy and best medical therapy (BMT) vs. BMT alone. The main exclusion criteria with regard to imaging were evidence of recent intracranial hemorrhage; and the presence on CT, CTA source images, or MRI of a large infarct in the brain stem, defined as a Pons-Midbrain Index of more than 3 points (range, 0 to 8, with higher values indicating more infarct burden; 1 point is attributed to infarction of <50% and 2 points to infarction of ≥50% on one side of the pons or midbrain). The primary outcome will be the proportion of patients achieving modified Rankin Scale (mRS) 0–3 at 90 days. Key secondary outcomes are: ordinal (shift) mRS analysis at 90 days, dichotomized mRS score (0–2 vs. 3–6 and 0–4 vs. 5–6) at 90 days, vessel recanalization at 24 hours in both treatment arms, and successful recanalization in the thrombectomy arm according to the modified thrombolysis in cerebral infarction (mTICI) classification defined as mTICI 2 b or 3. Safety outcomes are mortality at 90 days, symptomatic intracranial hemorrhage rates at 24 hours, and procedure-related complications.
Results: This trial is currently being prepared and will soon begin.
Conclusions: Results from this trial will indicate whether mechanical thrombectomy plus best medical management is superior to best medical management alone in achieving favorable outcomes in subjects with large infarct stroke caused by basilar artery occlusion presenting within 24 hours from symptom onset.
  • Li, Chuanhui  ( Xuanwu Hospital of CCMU , Beijing , China )
  • Ji, Xunming  ( Capital Medical University , Beijing , China )
  • Author Disclosures:
    Chuanhui Li: DO NOT have relevant financial relationships | Xunming Ji: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Ongoing Clinical Trials Posters

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
10-Year Trend Analysis of Medicare Payment in Stroke Inpatient Hospital Admission

Wong Ka-ho, Krothapalli Neeharika, Littig Lauren, Champagne Alison, Majersik Jennifer, Reddy Vivek, De Havenon Adam

Both English and non-English speaking patients with large-vessel occlusion receive timely access to thrombectomy

Gallagher Aaron, Cote Andre, Tirschwell David

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)